2019
DOI: 10.1016/j.jacc.2019.08.1064
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
40
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 60 publications
(50 citation statements)
references
References 23 publications
9
40
1
Order By: Relevance
“…In our study, BRFA did not signi cantly increase the rate of PPI after surgery, which may be due to the fact that our surgeon was particularly careful to avoid damage of the atrioventricular node in the ablation area. The requirement for PPM has been reported to range from 4.5% to 13.3% in several studies [22][23] [24]. In our cohort, 9.52% of patients received a PPM in the 6 months after surgery, which matched with the previous studies mentioned above.…”
Section: Discussionsupporting
confidence: 86%
“…In our study, BRFA did not signi cantly increase the rate of PPI after surgery, which may be due to the fact that our surgeon was particularly careful to avoid damage of the atrioventricular node in the ablation area. The requirement for PPM has been reported to range from 4.5% to 13.3% in several studies [22][23] [24]. In our cohort, 9.52% of patients received a PPM in the 6 months after surgery, which matched with the previous studies mentioned above.…”
Section: Discussionsupporting
confidence: 86%
“…In this context, prior work has shown that patients who develop a late requirement for PPM after valve surgery have more comorbidity associated with an increased risk for heart block and bradycardia unrelated to surgery. 20 In our population, when comorbidity was updated timedependently throughout follow-up, the hazard ratios of heart failure associated with late implantation of PPM was mitigated, supporting that the indication (opposite to the PPM placement) that was associated with increased heart failure risk. Other important differences between our study and the study by DeRose et al 23 include our analysis being restricted to patients without heart failure at baseline, whereas in the population by DeRose et al, 23 almost half of all patients had preoperative heart failure.…”
Section: Discussionsupporting
confidence: 57%
“…The incidence of postprocedural PPM implantation may range from 4.3% to 30% in different patient populations underwent transcatheter or surgical PV replacement 3,12‐14 . This rate can even mount to as high as 39% in patients underwent TAVR with the CoreValve system according to Fraccaro's research 15 .…”
Section: Discussionmentioning
confidence: 99%
“…Atrioventricular heart block is a common complication in patients received prosthetic valve (PV) implantation. The incidences ranging from 5% to 30% in patients underwent transcatheter aortic valve replacement (TAVR), approximately 5% to 10% in patients received surgical aortic valve replacement (SAVR), about 27% in patients following surgical tricuspid valve replacement (TVR) and 4.5% to 10.5% in patients underwent mitral valve repairmen (MVr) or mitral valve replacement (MVR) 1‐4 . It is widely known that conduction abnormalities (CAs) and right ventricular pacing (RVP) subsequently to PV implantation may induce electrical asynchrony, cardiac contraction asynchrony, atrial fibrillation (AF), heart failure, and early or late all‐cause mortality during short‐term or long‐term observation 5,6 .…”
Section: Introductionmentioning
confidence: 99%